From Almost Universally Fatal to Largely Treatable iTTP – American Society of Hematology
American Society of Hematology shared a post on LinkedIn about a recent article by Ahmet Emre Eşkazan, published in The Hematologist, adding:
“Immune-mediated thrombocytopenic purpura (iTTP) has undergone one of the most remarkable transformations in modern hematology.
Once considered almost universally fatal, it is now a largely treatable disease due to advances in therapeutic plasma exchange (TPE), immunosuppression, and targeted therapy.
Nevertheless, important challenges remain in early diagnosis, equitable access to treatment, relapse prevention, and long-term patient outcomes.”
Title: Small Vessels, Big Consequences: Immune-Mediated Thrombotic Thrombocytopenic Purpura
Authors: Ahmet Emre Eşkazan
Other posts featuring ASH on Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026